New tool developed to help guide pancreatic cyst... ( As a result of improved imaging tech...)

New tool developed to help guide pancreatic cyst treatment

Date:2/24/2010

As a result of improved imaging technology, pancreatic cysts are increasingly diagnosed in asymptomatic individuals who undergo scans for other reasons. And while most of these cysts follow a benign course, a small but significant number are either malignant at the time of diagnosis or have the potential to develop into pancreatic cancer during a patient's lifetime.

The dilemma for both patient and clinician is determining which cysts to leave alone and which to surgically remove. Existing treatment guidelines don't clearly address many treatment options beyond the removal of part of the pancreas a major undertaking for an asymptomatic lesion.

Now, a UCLAVeterans Affairs research team has developed an evaluation tool to help guide asymptomatic pancreatic cyst treatment. Published in the February issue of the journal Gastroenterology, the tool takes into account overall health, age, cyst size, surgical risk and patients' views about quality of life.

"Surgery may not be the best initial approach for all patients diagnosed with a specific pancreatic cyst. The new tool may help with decision-making and mapping out a treatment plan," said study author Dr. Brennan Spiegel, director of the UCLAVA Center for Outcomes Research and Education at the David Geffen School of Medicine at UCLA and the VA Greater Los Angeles Healthcare System.

The diagnosis of asymptomatic cysts has increased fivefold over the past decade, due partly to an aging population and to improved diagnostics. Current imaging techniques including computed tomography (CT), magnetic resonance imaging (MRI) and endoscopic ultrasound, in which a small camera is inserted down the throat and into the stomach and small bowel to image the pancreas combined with pancreatic cyst fluid analysis, offer an 80 percent accuracy in cyst diagnosis.

"Pancreatic cysts are most often diagnosed in an older population, and although many are benign, these
'/>"/>

Contact: Rachel Champeau
rchampeau@mednet.ucla.edu
310-794-2270
University of California - Los Angeles
Source:Eurekalert

0

GOOD

Page: 1 2 3
Related medicine news :

1. Flightless mosquitoes developed to help control dengue fever
2. Hair Cloning Not Yet Recommended by Researchers Who Developed the Technique
3. FDA clears TransOral robotic surgery developed at Penn
4. Synthetic Red Blood Cells Developed
5. Health Education Solutions Expands Online Course Offerings with eLearning Curricula Developed by American Heart Association
6. Viagra for women? Drug developed as antidepressant effective in treating low libido
7. CAP Proposes Improved Oversight of Lab-Developed Tests
8. Data Released at an International Stem Cell Meeting Highlights Effectiveness of New Patient Education System Developed to Support Federal and State Guidelines on Cord Blood Education
9. Surgeon Battling Own Cancer Developed New Treatment
10. Emergency Preparedness Simulation Scenarios Developed for Disaster Training Utilizing Laerdals VitalSim(TM) Product Line
11. Advanced Alopecia Treatment developed by London-based Hair Replacement Provider

Post Your Comments:

(Date:5/23/2013)... May 23, 2013 Da Vinci surgical ... a trial in Washington State May 23, according to ... in surgical robot lawsuits , expresses disappointment in ... Vinci lawsuits to not read a single verdict as ... (Estate of Fred E. Taylor v. Intuitive Surgical Inc.; ...

(Date:5/23/2013)... News) -- People who eat at fast-food restaurants are ... teens are the worst offenders, a new study found. ... meals by as much as 34 percent, parents of ... adults by as much as 20 percent," study lead ... from the Robert Wood Johnson Foundation, which helped fund ...

(Date:5/23/2013)... 2013 “Talk. They Hear You.” a ... parents to talk to children as young as nine ... launched today by the Substance Abuse and Mental Health ... conjunction with SAMHSA’s 2013 National Prevention Week—an annual health ... substance abuse and mental health issues. , SAMHSA’s latest ...

(Date:5/23/2013)... drug about to be tested in a clinical trial ... treatment for Alzheimer,s disease has failed to work with ... patients, according to results of a study by University ... of neuroscience affiliated with the Evelyn F. and William ... emphasized the importance of verifying promising research results before ...

(Date:5/23/2013)... New York, New York (PRWEB) May 23, 2013 ... products manufactured by C.R. Bard, Inc., continue to move ... District Court, Southern District of West Virginia, Bernstein Liebhard ... 17th, the Court denied a request by C.R. Bard ... claimed would reveal trade secrets and other confidential, proprietary ...

Breaking Medicine News(10 mins):Health News:Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group LLP Comments on Intuitive Win in Negligent Training Trial 2 Health News:How Many Calories in Your Fast-Food Meal? Guess Again 2 Health News:New Campaign to Help Parents Talk to Younger Children About the Dangers of Underage Drinking 2 Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 2 Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 3 Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 2 Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 3

[0] Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group LLP Comments on Intuitive Win in Negligent Training Trial [0] How Many Calories in Your Fast-Food Meal? Guess Again [0] New Campaign to Help Parents Talk to Younger Children About the Dangers of Underage Drinking [0] Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study [0] Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits

... Universal Health Services, Inc. (NYSE: UHS ) ... pay a cash dividend of $0.08 per share on ... June 1, 2009.Universal Health Services, Inc. is one of ... acute care and behavioral health hospitals, and ambulatory centers ...

... New grants will serve communities in outstate Minnesota ... of Directors approved four regional grants dedicated to ... and policy advocacy. The grants will provide resources ... new grant awards show our continuing commitment to ...

... Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical ... million in a second Series A financing extension ... was again led by Vivo Ventures. This capital ... development activities and strategic business objectives."Sagent,s business model ...

... The American Association for Homecare supports expanded anti-fraud efforts ... and the Department of Health and Human Services (HHS) ... two agencies outlined plans for expanding anti-fraud strike forces ... Care Fraud Prevention and Enforcement Action Team. Even ...

... dialysis patients, quality of life, study says , , WEDNESDAY, ... and the anti-clotting drug dipyridamole reduces blockages and extends ... for kidney dialysis, new research has found. , When ... stenosis -- a narrowing of blood vessels -- at ...

... to flu variant that circulated before 1957 , , WEDNESDAY, May ... immunity to the new H1N1 swine flu virus because of ... 1957, a U.S. infectious-disease expert said Wednesday. , "The further ... to have been exposed to H1N1 virus back before 1957, ...

Universal Health Services, Inc. Announces Dividend ClearWay Minnesota(SM) Board Approves Four Regional Grants Sagent Pharmaceuticals Announces Extension of Series A Financing American Association for Homecare Supports Expanded Federal Efforts by DOJ and HHS to Combat Medicare Fraud Drug Combo Keeps Kidney Artery-Vein Grafts Viable Older Adults May Have Some Immunity to Swine Flu

(Date:5/23/2013)... 3SBio Inc. (NASDAQ: SSRX ... China -based biotechnology company focused on ... today that, at an extraordinary general meeting held ... favor of the proposal to authorize and approve ... dated February 8, 2013, among Decade Sunshine Limited, ...

(Date:5/23/2013)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ) ... Life Science Firm of the Year by the Tech Council ... at the TCM,s 25 th Annual Tech Awards Celebration ... Awards Celebration recognizes the leaders and innovators in the technology ... and the surrounding regions. "We are deeply ...

(Date:5/23/2013)... de mayo de 2013 Volcano Corporation (NASDAQ: ... fabricante de herramientas de precisión para terapia guiadas ... la enfermedad vascular periférica y coronaria, anunció hoy ... enosine V asodilator I ndependent ... sesión de ensayo clínico hot line late breaking ...

Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 2 3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3 Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6

[0] 3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement [0] Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland [0] Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2

... Open enrollment is an opportune time to find the best ... 15 Through the end of the year, thousands of Nebraska ... This is when the state,s 268,000 Medicare beneficiaries get to ... in 2010. , Prescription drug coverage is a critical part ...

... , , NEW YORK, Dec. ... research report is available in its catalogue: , ... the U.S. and its International Trade [Q4 2009 ... just released December edition of Surgical and Medical ...

Cached Medicine Technology:Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8

Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition]

... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

Medicine Products:

Allergen, Tree,Baccharus Spp/Groundsel Tree Allergen, Parasite, Ascaris Allergen, Occupational, Phthalic Anhydride Allergen, Occupational, Formaldehyde